Inpatients being administered high doses and those who are at risk of receiving high doses (where the prescription of regular and PRN antipsychotic doses could potentially lead to HDAT) should be identified by means of a sticker attached by pharmacy staff to the drug prescription and ...
Williams I, Bryan S. Cost-effectiveness analysis and formulary decision making in England: findings from research. Soc Sci Med. 2007;65:2116–29.. Offredy M. An exploratory study of the role and training needs of one primary care trust’s professional executive committee members. Prim Health ...
The British National Formulary for Children (BNFc) dosing guidance, for which there is ... K Petrie,C O’Brien,S Bhushan,... - 《European Journal of Hospital Pharmacy Science & Practice》 被引量: 2发表: 2014年 Sharing the journey ... of setting up a Tissue Viability Service in NHS ...
Qualitative changes in antibiotic use were introduced in May 2007 with a review of approved and recommended antibiotics by the microbiology and pharmacy departments, to achieve a limitation on the use of common classes of broad spectrum agents (e.g., cephalosporins, quinolones, macrolides) where ...